banner ad

Pharmaceutical Marketing Consultant Harry Boghigian

Harry C. Boghigian
Owner/Founder
23850 Via Italia Circle 406
Bonita Springs FL 34134
USA
phone: 973-476-6591
Harry-Boghigian-Pharmaceutical-Marketing-Expert-Photo.jpg
Pharma Consultants LLC has been assisting entrepreneurs and small to medium size pharmaceutical companies in the development and implementation of successful and innovative Pharmaceutical Product Marketing Strategies for years.

Pharma Consultants LLC specializes in developing and consulting on strategies and tactics for prescription, OTC, and healthcare related products. They provide custom work servicing advertising agencies, biotech, pharmaceutical,health related companies and conduct expert reports on products for domestic and international law firms on behalf of their clients.

Pharma Consultants has a broad range of experience and expertise in a number of areas:
  • Market Research
  • Consultant Meetings
  • Co-promotion Arrangements
  • Business Development
  • Slowing the Erosion of Patent Expired Products
  • Contract Product Marketing
  • Product Market Strategies and Promotion
  • Product Positioning
  • President, Harry C. Boghigian is a Pharmaceutical Executive with over 40 years of industry experience both domestically and internationally. His experience ranges from sales through the ranks into numerous senior positions of responsibility both in the US and abroad.

    Mr. Boghigian's expertise in co-promotion arrangements, new product development, and global marketing across numerous therapeutic areas contributed to his record of successes.

    Mr. Boghigian has worked for Hoffmann-LaRoche, one of the top 5 pharma companies in the world both domestically and internationally, rising to senior executive levels of management and board positions in addition to being part owner in a boutique pharma company, PBN PHARMA, which introduced two all-natural products into the market. In 2002, he founded Pharma Consultants LLC, a consulting company catering to entrepreneurs and small start-up and medium size pharmaceutical companies.

    View